Concepedia

Brian Terry

BT

Statistics

Publications

28

Citations

1.6K

H-Index

22

Active since

1979

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Duke University Hospital

Duke Medical Center

Brian Terry is an author at Bristol-Myers Squibb (United States) specializing in antiviral agents, life sciences, and antiviral pharmacology.

Publications per year

1979–2020

28

Publications

28

BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents

Brett S. Robinson, Keith Riccardi, Yi-Fei Gong et al. · Antimicrobial Agents and Chemotherapy · 2000 · 196 citations

, , +17

Involvement of outside DNA sequences in the major kinetic path by which EcoRI endonuclease locates and leaves its recognition sequence.

William E. Jack, Brian Terry, Paul Modrich · Proceedings of the National Academy of Sciences · 1982 · 177 citations · Full text

, , +17

Facilitated diffusion during catalysis by EcoRI endonuclease. Nonspecific interactions in EcoRI catalysis.

Brian Terry, William E. Jack, Paul Modrich · Journal of Biological Chemistry · 1985 · 174 citations · Full text

, , +17

Thermodynamic parameters governing interaction of EcoRI endonuclease with specific and nonspecific DNA sequences.

Brian Terry, William E. Jack, Robert A. Rubin et al. · Journal of Biological Chemistry · 1983 · 146 citations · Full text

, , +15

Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.

R.E. Rose, Ying Gong, Jill A. Greytok et al. · Proceedings of the National Academy of Sciences · 1996 · 117 citations

, , +17

1–5 of 28